Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Alzheimer’s drug donanemab helps most when taken at earliest disease stage, study finds

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 619, 682-683 (2023)

doi: https://doi.org/10.1038/d41586-023-02321-1

Updates & Corrections

  • Update 17 July 2023: This story has been updated with additional comment from scientists not involved in the research.

References

  1. Sims, J. R. et al. JAMA https://doi.org/10.1001/jama.2023.13239 (2023).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links